Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
continuous glucose monitor
MedTech
FDA clears Senseonics' 365-day Eversense CGM implant
Developed by Senseonics and Ascensia Diabetes Care, the Eversense 365 implant got the go-ahead for adults with Type 1 or Type 2 diabetes.
Conor Hale
Sep 17, 2024 11:00am
Over-the-counter CGM market grows, with Abbott’s Lingo debut
Sep 5, 2024 12:00pm
Dexcom launches its first over-the-counter glucose monitor
Aug 26, 2024 7:00am
Abbott, Medtronic team up to link CGM, insulin delivery systems
Aug 7, 2024 12:00pm
Dexcom down 40% after CGM sales challenges
Jul 26, 2024 11:30am
Abbott recalls some CGM sensors after inaccurate readings
Jul 25, 2024 2:00pm